184 related articles for article (PubMed ID: 35857172)
1. The feasibility of ultralow-activity
Lv J; Yin H; Yu H; Liu G; Shi H
Ann Nucl Med; 2022 Oct; 36(10):887-896. PubMed ID: 35857172
[TBL] [Abstract][Full Text] [Related]
2. Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of
Liu G; Hu P; Yu H; Tan H; Zhang Y; Yin H; Hu Y; Gu J; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2373-2383. PubMed ID: 33479842
[TBL] [Abstract][Full Text] [Related]
3. Ultralow-dose [
Tan H; Qi C; Cao Y; Cai D; Mao W; Yu H; Sui X; Liu G; Shi H
Eur Radiol; 2023 Jul; 33(7):5017-5027. PubMed ID: 36688971
[TBL] [Abstract][Full Text] [Related]
4. Dynamic total-body PET/CT imaging with reduced acquisition time shows acceptable performance in quantification of [
Liu G; Shi Y; Hou X; Yu H; Hu Y; Zhang Y; Shi H
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1371-1382. PubMed ID: 38078950
[TBL] [Abstract][Full Text] [Related]
5. Assessment of tumour response after stereotactic ablative radiation therapy for lung cancer: A prospective quantitative hybrid
Yang DM; Palma D; Louie A; Malthaner R; Fortin D; Rodrigues G; Yaremko B; Laba J; Gaede S; Warner A; Inculet R; Lee TY
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):94-101. PubMed ID: 30281918
[TBL] [Abstract][Full Text] [Related]
6. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer.
Tan H; Sui X; Yin H; Yu H; Gu Y; Chen S; Hu P; Mao W; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1966-1975. PubMed ID: 33244618
[TBL] [Abstract][Full Text] [Related]
7. Kinetic metrics of
Liu G; Xu H; Hu P; Tan H; Zhang Y; Yu H; Li X; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2363-2372. PubMed ID: 33416959
[TBL] [Abstract][Full Text] [Related]
8. Short-time total-body dynamic PET imaging performance in quantifying the kinetic metrics of
Liu G; Yu H; Shi D; Hu P; Hu Y; Tan H; Zhang Y; Yin H; Shi H
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2493-2503. PubMed ID: 34417855
[TBL] [Abstract][Full Text] [Related]
9. Nucleophosmin 1 overexpression correlates with
Zhou LM; Yuan LL; Gao Y; Liu XS; Dai Q; Yang JW; Pei ZJ
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):904-912. PubMed ID: 32856112
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Image quality and lesion detectability in low-dose pediatric
Zhao YM; Li YH; Chen T; Zhang WG; Wang LH; Feng J; Li C; Zhang X; Fan W; Hu YY
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3378-3385. PubMed ID: 33738519
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of dynamic
Sun Y; Xiao L; Wang Y; Liu C; Cao L; Zhai W; Wang B; Yu S; Xin J
Quant Imaging Med Surg; 2023 Apr; 13(4):2556-2567. PubMed ID: 37064404
[TBL] [Abstract][Full Text] [Related]
13. First results on kinetic modelling and parametric imaging of dynamic
Sari H; Mingels C; Alberts I; Hu J; Buesser D; Shah V; Schepers R; Caluori P; Panin V; Conti M; Afshar-Oromieh A; Shi K; Eriksson L; Rominger A; Cumming P
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1997-2009. PubMed ID: 34981164
[TBL] [Abstract][Full Text] [Related]
14. Short dynamic FDG-PET imaging protocol for patients with lung cancer.
Torizuka T; Nobezawa S; Momiki S; Kasamatsu N; Kanno T; Yoshikawa E; Futatsubashi M; Okada H; Ouchi Y
Eur J Nucl Med; 2000 Oct; 27(10):1538-42. PubMed ID: 11083544
[TBL] [Abstract][Full Text] [Related]
15. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.
Guo J; Guo N; Lang L; Kiesewetter DO; Xie Q; Li Q; Eden HS; Niu G; Chen X
J Nucl Med; 2014 Jan; 55(1):154-60. PubMed ID: 24232871
[TBL] [Abstract][Full Text] [Related]
16. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
17. Utility of Maximum Standard Uptake Value as a Predictor for Differentiating the Invasiveness of T1 Stage Pulmonary Adenocarcinoma.
Fu L; Alam MS; Ren Y; Guan W; Wu H; Wang Q; Han Y; Zhou W; Li H; Wang Z
Clin Lung Cancer; 2018 May; 19(3):221-229. PubMed ID: 29275041
[TBL] [Abstract][Full Text] [Related]
18. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [
Chen W; Liu L; Li Y; Li S; Li Z; Zhang W; Zhang X; Wu R; Hu D; Sun H; Zhou Y; Fan W; Zhao Y; Zhang Y; Hu Y
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4145-4155. PubMed ID: 35788704
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of dual-time
Pahk K; Chung JH; Kim S; Lee SH
Tumori; 2018 Jun; 104(3):207-212. PubMed ID: 29714664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
